Jereme M. Sylvain - 22 May 2026 Form 4 Insider Report for DEXCOM INC (DXCM)

Reporting relationship: EVP, Chief Financal Officer
Issuer ticker: DXCM
Reported as of: 22 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 May 2026, 16:39:05 UTC
Prior SEC filing: 10 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Jereme M. Sylvain

Key filing fact

Jereme M. Sylvain filed Form 4 for DEXCOM INC (DXCM) on 27 May 2026.

Key facts

This page summarizes Jereme M. Sylvain's Form 4 filing for DEXCOM INC (DXCM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 May 2026, 16:39.

Change

Previous filing in this sequence was filed on 10 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001681267 Primary reporting owner

Sylvain Jereme M

Relationship: EVP, Chief Financal Officer
Address: 6340 SEQUENCE DRIVE, SAN DIEGO
Signature: /s/ Jereme M. Sylvain
Signature date: 27 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DXCM transaction

Common Stock

Tax liability

Transaction value
Shares: -1,451
Change %: -0.95%
Price: $71.90^*
Shares after: 151,841
Date: 22 May 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person.

Footnote F2

Included in this number are 89,944 unvested restricted stock units, 48,774 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 23,937 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 8,549 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 8,684 of which were granted on March 8, 2024 and shall vest through March 8, 2027.